Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study

Benzinga12/18 02:05

Bayer Partners With America's Grow-A-Row to Aid in the Fight Against Hunger in New Jersey

Businesswire12/17 21:10

Bayer's Eye Drug Shows Positive Results in Late-Stage Trial

WSJ12/17 20:56

Regeneron Posts Phase 3 Win for Eylea HD in Retinal Vein Occlusion

Seeking Alpha12/17 20:49

Kyorin Pharmaceutical Secures Exclusive License for Bayer's Novel OSA Treatment

MT Newswires12/16 19:28

Bayer's Cardiomyopathy Drug Acoramidis Backed for Approval in EU

MT Newswires12/13 20:10